Results overview: Found 2 records in 0.02 seconds.
Articles, 2 records found
Articles 2 records found  
1.
12 p, 385.6 KB Compromised fidelity of B-cell tolerance checkpoints in AChR and MuSK myasthenia gravis / Lee, Jae-Yun (Yale School of Medicine. Department of Neurology) ; Stathopoulos, Panos (Yale School of Medicine. Department of Neurology) ; Gupta, Sasha (Yale School of Medicine. Department of Neurology) ; Bannock, Jason M. (Yale School of Medicine. Department of Immunobiology) ; Barohn, Richard J. (University of Kansas Medical Center. Department of Neurology) ; Cotzomi, Elizabeth (Yale School of Medicine. Department of Neurology) ; Dimachkie, Mazen M. (University of Kansas Medical Center. Department of Neurology) ; Jacobson, Leslie (University of Oxford. Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital) ; Lee, Casey S. (Yale School of Medicine. Department of Neurology) ; Morbach, Henner (Yale School of Medicine. Department of Immunobiology) ; Querol, Luis (Institut d'Investigació Biomèdica Sant Pau) ; Shan, Jing-Li (Yale School of Medicine. Department of Neurology) ; Vander Heiden, Jason A. (Yale University. Interdepartmental Program in Computational Biology and Bioinformatics) ; Waters, Patrick (University of Oxford. Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital) ; Vincent, Angela (University of Oxford. Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital) ; Nowak, Richard J. (Yale School of Medicine. Department of Neurology) ; O'Connor, Kevin C. (Yale School of Medicine. Department of Neurology) ; Universitat Autònoma de Barcelona
Myasthenia gravis () is an autoimmune condition in which neurotransmission is impaired by binding of autoantibodies to acetylcholine receptors (hR) or, in a minority of patients, to muscle specific kinase (Mu). [...]
2016 - 10.1002/acn3.311
Annals of Clinical and Translational Neurology, Vol. 3, Issue 6 (June 2016) , p. 443-454  
2.
11 p, 1.3 MB Multicentre comparison of a diagnostic assay : aquaporin-4 antibodies in neuromyelitis optica / Waters, Patrick (University of Oxford) ; Reindl, Markus (Medical University of Innsbruck) ; Saiz, Albert (Neuroimmunology Program, Hospital Clinic and Institut d'Investigació Biomèdica August Pi i Sunyer (IDIBAPS), Universitat de Barcelona) ; Schanda, Kathrin (Medical University of Innsbruck) ; Tuller, Friederike (Medical University of Innsbruck) ; Kral, Vlastimil (Zdravotni ustav se sidlem v Usti nad Labem, Centrum imunologie a mikrobiologie) ; Nytrova, Petra (Center of Clinical Neuroscience First Faculty of Medicine, General University Hospital and First Faculty of Medicine, Charles University in Prague) ; Sobek, Ondrej (Topelex Ltd) ; Nielsen, Helle Hvilsted (Odense University Hospital) ; Barington, Torben (Odense University Hospital) ; Lillevang, Søren T (Odense University Hospital) ; Illes, Zsolt (University of Pécs) ; Rentzsch, Kristin (Euroimmun AG) ; Berthele, Achim (Klinikum rechts der Isar der TU München, Klinik für Neurologie) ; Berki, Tímea (University of Pécs) ; Granieri, Letizia (Neuroscience Institute Cavalieri Ottolenghi (NICO), University Hospital San Luigi Gonzaga, Regional Referring Multiple Sclerosis Centre) ; Bertolotto, Antonio (Neuroscience Institute Cavalieri Ottolenghi (NICO), University Hospital San Luigi Gonzaga, Regional Referring Multiple Sclerosis Centre) ; Giometto, Bruno (Azienda ULSS 9 Treviso) ; Zuliani, Luigi (Azienda ULSS 9 Treviso) ; Hamann, Dörte (Sanquin Diagnostic Services, Department of Immunopathology and Blood Coagulation, Amsterdam) ; van Pelt, E Daniëlle (MS Centre ErasMS, Erasmus MC) ; Hintzen, Rogier (MS Centre ErasMS, Erasmus MC) ; Höftberger, Romana (Medical University of Vienna. Institute of Neurology) ; Costa, Carme (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Comabella, Manuel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Tintoré, Mar (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Siva, Aksel (Istanbul University, Cerrahpasa Medical School) ; Altintas, Ayse (Istanbul University, Cerrahpasa Medical School) ; Deniz, Günnur (Istanbul University, Institute of Experimental Medicine) ; Woodhall, Mark (University of Oxford) ; Palace, Jacqueline (University of Oxford) ; Paul, Friedemann (NeuroCure Clinical Research Center (NCRC), Charité Universitätsmedizin Berlin) ; Hartung, Hans-Peter (Heinrich-Heine-University Düsseldorf) ; Aktas, Orhan (Heinrich-Heine-University Düsseldorf) ; Jarius, Sven (University of Heidelberg) ; Wildemann, Brigitte (University of Heidelberg) ; Vedeler, Christian (Haukeland University Hospital) ; Ruiz, Anne (Lyon Neurosciences Research Centre, Neuro-inflammation and Neuro-oncology Team) ; Leite, M Isabel (University of Oxford) ; Trillenberg, Peter (University Hospital of Schleswig-Holstein, Campus Lübeck) ; Probst, Monika (Institute for Quality Assurance) ; Saschenbrecker, Sandra (Euroimmun AG) ; Vincent, Angela (University of Oxford) ; Marignier, Romain (Lyon Neurosciences Research Centre, Neuro-inflammation and Neuro-oncology Team) ; Universitat Autònoma de Barcelona
Antibodies to cell surface central nervous system proteins help to diagnose conditions which often respond to immunotherapies. The assessment of antibody assays needs to reflect their clinical utility. [...]
2016 - 10.1136/jnnp-2015-312601
Journal of Neurology, Neurosurgery, and Psychiatry, Vol. 87 (april 2016) , p. 1005-1015  

See also: similar author names
2 Waters, Paul D.
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.